Sapheon Inc. has been acquired by Covidien plc
Sapheon Inc., based in Santa Rosa, California, has been acquired by the Irish Covidien plc, a global healthcare products leader dedicated to innovation and long-term growth. Financial details have not been disclosed.
Sapheon Inc. is a medical device company whose mission is to develop new approaches and disruptive technologies for the treatment of vascular disease. The company’s current focus is the VenaSeal Sapheon Closure System, a novel treatment for venous reflux disease. Sapheon, Inc. will operate as a subsidiary of Covidien plc.
Covidien plc develops, manufactures, and sells healthcare products for use in clinical and home settings worldwide. Through its Medical Devices and Medical Supplies segments, the company creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence.
One of Oaklins' teams in the USA served as the exclusive financial advisor to the seller in this transaction.
Contacter l'équipe de la transaction
Michael S. Goldman
Oaklins TM Capital
Andy Krna
Oaklins TM Capital
James McLaren
Oaklins TM Capital
Transactions connexes
Perkbox has been acquired by Great Hill Partners
Molten Ventures has sold Perkbox to Great Hill Partners.
En apprendre plusArculus Cyber Security has been acquired by Bridewell
The shareholders of Arculus Cyber Security (Arculus) have sold the business to Bridewell. The deal will bolster Bridewell’s growing roster of accreditations as well as strengthen its public sector footprint, enabling the expansion of its end-to-end cyber security offering for clients across the globe.
En apprendre plusGlobal IT Group has joined forces with enthus Group
Global IT Group, an IT services company, and enthus Group GmbH, an IT solution provider operating in Germany, Austria and Switzerland, have joined forces. As a result, enthus Group will significantly expand its market position in Switzerland. The sellers of Global IT have reinvested in the buyer and will ensure that local management continues to run the company as part of the succession planning.
En apprendre plus